Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study.
Serra M, De Martino F, Savino F, D'Alesio V, Arrichiello C, Quarto M, Loffredo F, Di Franco R, Borzillo V, Muto M, Ametrano G, Muto P. Serra M, et al. Among authors: d alesio v. Life (Basel). 2022 May 10;12(5):711. doi: 10.3390/life12050711. Life (Basel). 2022. PMID: 35629378 Free PMC article.
Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity®: Outcomes, Toxicities and Dosimetric Evaluation.
Di Franco R, Borzillo V, Scipilliti E, Ametrano G, Serra M, Arrichiello C, Savino F, De Martino F, D'Alesio V, Cammarota F, Crispo A, Pignata S, Rossetti S, Quarto G, Muto P. Di Franco R, et al. Among authors: d alesio v. Cancers (Basel). 2022 Jun 29;14(13):3187. doi: 10.3390/cancers14133187. Cancers (Basel). 2022. PMID: 35804958 Free PMC article.
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Borzillo V, Scipilliti E, Pezzulla D, Serra M, Ametrano G, Quarto G, Perdonà S, Rossetti S, Pignata S, Crispo A, Di Gennaro P, D'Alesio V, Arrichiello C, Buonanno F, Mercogliano S, Russo A, Tufano A, Di Franco R, Muto P. Borzillo V, et al. Among authors: d alesio v. Front Oncol. 2023 Nov 7;13:1270498. doi: 10.3389/fonc.2023.1270498. eCollection 2023. Front Oncol. 2023. PMID: 38023175 Free PMC article.
A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells.
Borrelli A, Schiattarella A, Mancini R, Morrica B, Cerciello V, Mormile M, d'Alesio V, Bottalico L, Morelli F, D'Armiento M, D'Armiento FP, Mancini A. Borrelli A, et al. Among authors: d alesio v. Free Radic Biol Med. 2009 Jan 1;46(1):110-6. doi: 10.1016/j.freeradbiomed.2008.10.030. Epub 2008 Oct 25. Free Radic Biol Med. 2009. PMID: 18996183
Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.
Esposito M, Maggi G, Marino C, Bottalico L, Cagni E, Carbonini C, Casale M, Clemente S, D'Alesio V, Fedele D, Giglioli FR, Landoni V, Martinotti A, Nigro R, Strigari L, Villaggi E, Mancosu P. Esposito M, et al. Among authors: d alesio v. Phys Med. 2016 Jan;32(1):277-83. doi: 10.1016/j.ejmp.2015.09.009. Epub 2015 Oct 20. Phys Med. 2016. PMID: 26498378
3.0-T functional brain imaging: a 5-year experience.
Scarabino T, Giannatempo GM, Popolizio T, Tosetti M, d'Alesio V, Esposito F, Di Salle F, Di Costanzo A, Bertolino A, Maggialetti A, Salvolini U. Scarabino T, et al. Among authors: d alesio v. Radiol Med. 2007 Feb;112(1):97-112. doi: 10.1007/s11547-007-0124-x. Epub 2007 Feb 22. Radiol Med. 2007. PMID: 17310287 English, Italian.
The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study.
Leuzzi V, Tosetti M, Montanaro D, Carducci C, Artiola C, Carducci C, Antonozzi I, Burroni M, Carnevale F, Chiarotti F, Popolizio T, Giannatempo GM, D'Alesio V, Scarabino T. Leuzzi V, et al. Among authors: d alesio v. J Inherit Metab Dis. 2007 Apr;30(2):209-16. doi: 10.1007/s10545-006-0399-4. Epub 2007 Jan 23. J Inherit Metab Dis. 2007. PMID: 17245558